acid treatment elderly patients acute myeloid leukemia phase II pilot study Eastern Cooperative Oncology Group management acute myeloid leukemia elderly years unsatisfactory poor patient tolerance standard myeloablative chemotherapy authors Phase II study effectiveness toxicity acid CRA therapy elderly patients acute myeloid leukemia AML Patients leukocyte counts CRA leukocyte counts hydroxyurea CRA Twelve patients weeks CRA evaluable toxicity response objective responses Cis-retinoic acid administration modest dermatologic musculoskeletal gastrointestinal toxicity Alternative therapeutic strategies subpopulation AML patients 